ACM Biolabs Announces Positive Topline Results from a Phase I Trial of SARS-CoV-2 Booster Vaccine ACM-001
/PRNewswire/ -- ACM Biolabs, a biotechnology company using its next-generation polymer-based delivery platform to develop new nano formulations for use in...
New South Wales Pierre Vandepapeli Madhavan Nallani Biolabs Pty Ltd Tunable Platform Chief Executive Officer
Source: prnewswire.co.uk